9RL-28425-62217
2 vaccinations
3 coded responses
18 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 276 / NC
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- NJE-73816-33340
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Dose 1 — Pfizer-BioNTech
-
2022-06-30
Registered in v-safe
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain, Redness · Fever · Sleepiness, Irritability/crying · Be unable to work or attend school, Be unable to do your normal daily activitiesUnder 3 check-in
-
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain, Redness · Fever · Sleepiness, Irritability/crying · Be unable to work or attend schoolUnder 3 check-in
- 2022-07-03
- 2022-07-04
-
2022-07-11
Survey response — day 14, dose 1, under 3MedDRA: Cough, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Bad cough, mild feverMedDRA releases: 2024-11 · check-in free text available
- 2022-07-18
-
2022-07-22
Dose 2 — Pfizer-BioNTechCo-administered: Hepatitis A
-
2022-07-25
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Angioedema, Injection site reaction, Office visit, Urticaria — Feeling: Fair · Site: Redness, Swelling/hardness, Groin or underarm swelling/tenderness · Fever · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Full body hives, angioedema of hands, feet and legs · Healthcare visit (other): Pediatrician consulted reaction site and consulted allergistMedDRA releases: 2024-11 · check-in free text available
-
2022-07-25
Report sent to call center — days 1–6 daily, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-26
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Oedema, Urticaria — Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteFree text: Still covered in hives but getting better, edema has gone downMedDRA releases: 2024-11 · check-in free text available
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-29
- 2022-08-05
- 2022-08-12
- 2022-08-19
- 2022-08-26
- 2022-09-02
- 2022-10-21
- 2023-01-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Pfizer-BioNTech | No |
| 2 | 2022-07-22 | Pfizer-BioNTech | Hepatitis A |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Bad cough, mild fever
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Full body hives, angioedema of hands, feet and legs
Healthcare visit (other): Pediatrician consulted reaction site and consulted allergist
Systemic reaction (other): Still covered in hives but getting better, edema has gone down
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Injection site reaction | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Angioedema | · | · | ✓ |
| SRO | Oedema | · | · | ✓ |
| SRO | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release